.GIF?ad=16177&adview=true)
![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RESEARCH PAPER
1 Department of Biological Sciences, Columbia University, New York, New York 10027, USA; 2 Chemistry Department, Hunter College, City University of New York, New York, New York 10021, USA; 3 Department of Pathology, Institute for Cancer Genetics, Medical Center, Columbia University, New York, New York 10032, USA
Mammalian cells exhibit a complex response to DNA damage. The tumor suppressor BRCA1 and associated protein BARD1 are thought to play an important role in this response, and our previous work demonstrated that this includes transient inhibition of the pre-mRNA 3' processing machinery. Here we provide evidence that this inhibition involves proteasomal degradation of a component necessary for processing, RNA polymerase II (RNAP II). We further show that RNAP IIO, the elongating form of the enzyme, is a specific in vitro target of the BRCA1/BARD1 ubiquitin ligase activity. Significantly, siRNA-mediated knockdown of BRCA1 and BARD1 resulted in stabilization of RNAP II after DNA damage. In addition, inhibition of 3' cleavage induced by DNA damage was reverted in extracts of BRCA1-, BARD1-, or BRCA1/BARD1-depleted cells. We also describe corresponding changes in the nuclear localization and/or accumulation of these factors following DNA damage. Our results support a model in which a BRCA1/BARD1-containing complex functions to initiate degradation of stalled RNAP IIO, inhibiting the coupled transcription-RNA processing machinery and facilitating repair.
[Keywords: BARD1; BRCA1; RNA polymerase II; polyadenylation]
Received February 23, 2005; revised version accepted April 8, 2005.
E-MAIL jlm2{at}columbia.edu; FAX (212) 865-8246.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Pavelitz, A. D. Bailey, C. P. Elco, and A. M. Weiner Human U2 snRNA Genes Exhibit a Persistently Open Transcriptional State and Promoter Disassembly at Metaphase Mol. Cell. Biol., June 1, 2008; 28(11): 3573 - 3588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Heine, A. A. Horwitz, and J. D. Parvin Multiple Mechanisms Contribute to Inhibit Transcription in Response to DNA Damage J. Biol. Chem., April 11, 2008; 283(15): 9555 - 9561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mirkin, D. Fonseca, S. Mohammed, M. A. Cevher, J. L. Manley, and F. E. Kleiman The 3' processing factor CstF functions in the DNA repair response Nucleic Acids Res., April 1, 2008; 36(6): 1792 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lin and J. H. Wilson Transcription-Induced CAG Repeat Contraction in Human Cells Is Mediated in Part by Transcription-Coupled Nucleotide Excision Repair Mol. Cell. Biol., September 1, 2007; 27(17): 6209 - 6217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Heine and J. D. Parvin BRCA1 Control of Steroid Receptor Ubiquitination Sci. Signal., June 19, 2007; 2007(391): pe34 - pe34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Horwitz, E. B. Affar, G. F. Heine, Y. Shi, and J. D. Parvin A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase PNAS, April 17, 2007; 104(16): 6614 - 6619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wu, H. Nishikawa, R. Hayami, K. Sato, A. Honda, S. Aratani, T. Nakajima, M. Fukuda, and T. Ohta BRCA1 Ubiquitinates RPB8 in Response to DNA Damage Cancer Res., February 1, 2007; 67(3): 951 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moisan and L. Gaudreau The BRCA1 COOH-terminal Region Acts as an RNA Polymerase II Carboxyl-terminal Domain Kinase Inhibitor That Modulates p21WAF1/CIP1 Expression J. Biol. Chem., July 28, 2006; 281(30): 21119 - 21130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yu, S. Fu, M. Lai, R. Baer, and J. Chen BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes & Dev., July 1, 2006; 20(13): 1721 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Newman, A. D. Bailey, and A. M. Weiner Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling PNAS, June 20, 2006; 103(25): 9613 - 9618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Kim, H. Li, M. Cevher, A. Parmelee, D. Fonseca, F. E. Kleiman, and S. B. Lee DNA Damage-Induced BARD1 Phosphorylation Is Critical for the Inhibition of Messenger RNA Processing by BRCA1/BARD1 Complex. Cancer Res., May 1, 2006; 66(9): 4561 - 4565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Q. Dai-Ju, L. Li, L. A. Johnson, and R. M. Sandri-Goldin ICP27 Interacts with the C-Terminal Domain of RNA Polymerase II and Facilitates Its Recruitment to Herpes Simplex Virus 1 Transcription Sites, Where It Undergoes Proteasomal Degradation during Infection. J. Virol., April 1, 2006; 80(7): 3567 - 3581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jung and S. J. Lippard RNA Polymerase II Blockage by Cisplatin-damaged DNA: STABILITY AND POLYUBIQUITYLATION OF STALLED POLYMERASE J. Biol. Chem., January 20, 2006; 281(3): 1361 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Chapman, M. Conrad, and D. Eick Role of the Mammalian RNA Polymerase II C-Terminal Domain (CTD) Nonconsensus Repeats in CTD Stability and Cell Proliferation Mol. Cell. Biol., September 1, 2005; 25(17): 7665 - 7674. [Abstract] [Full Text] [PDF]
|
|
